We’ve all gone a little bit crackers on Friday – or as the Kiwi’s like to say in French – un peu fou de fafa.

Trading volumes – unless I’m drunk – are about double what they usually are. Wait… 95% above the 20-day moving average. It’s a lot.

All in all it’s a session more volatile than a French marriage, the S&P/ASX200 is up with a bullet, gaining circa 150 points or 2.2% and perhaps trying to wash clean the shame of yesterday’s mad descent into a technical correction.

The index has lost 2.6% over the last five days, but has gained a smidge over 5% for the year to date.

That sweet contrariness is worth the price of a croissant, at least.

 

BIG CAP WINNERS

Swipe or scroll to reveal the full table. Click headings to sort.

Imugene (ASX:IMU) is killing it ahead of the close. Not the best expression for an immunotherapy-biotech led by absolute legend Dr Leslie Chong but it ISA Friday.

IMU has secured a patent from the European Patent Office for the HER-Vaxx immunotherapy treatment. And I bet they’re hard to come by.

After shedding some 30% for the year, IMU stock is up near 9% for the day with the close at hand.

I suppose someone here should mention that once Anglo, now Aussie, miner BHP Billiton (ASX:BHP) , after about two decades of having its cake and eating it too, has returned to a  single-listing and a unification upweight on the local index well over 10% (from under 7%)  sending volumes through the roof, although the stock itself is only ahead about 3% on volumes x 3 its 20-day moving average.

 

BIG CAP LOSERS

Swipe or scroll to reveal the full table. Click headings to sort.

On the downside, Ramelius (ASX:RMS) is getting smashed thanks to the thinking man’s virus taking a chunk out of production. which the goldie now expects to limp in at the lower end of guidance. Code for missing guidance? I’d say about 8% of shareholders think that at 1530 AEST.

And Newcrest’s (ASXZ:NCM) Managing Director and Chief Executive Officer, Sandeep Biswas, is telling everyone how chuffed he is with the company’s performance during the quarter.

He’s gone totally rogue. The stock is crashing and production guidance is all wrong. Newcrest is this week’s in the corner with a funny hat stock.

NCM is trading about 6% lower, there are worse performances but none which contrast so nicely with what the boss is saying.

Do NOT listen to the boss, Australia. Here endeth the lesson.